88914-76-5

Upstream product

• 124-63-0 methanesulfonyl chloride 
• 88914-75-4 3-(N-benzylmethylamino)-4-nitroaniline 
• 103-67-3 benzyl-methyl-amine 
• 102940-79-4 N-[3-(Benzyl-methyl-amino)-4-nitro-phenyl]-acetamide 
• 712-33-4 3-chloro-4-nitroacetanilide 

Downstream Products

• 88913-59-1 N-[4-(4-Bromo-acridin-9-ylamino)-3-methylamino-phenyl]-methanesulfonamide 
• 102941-15-1 9-(4-Methanesulfonylamino-2-methylamino-phenylamino)-acridine-4-carboxylic acid carbamoylmethyl-amide; hydrochloride 
• 102941-16-2 1-Chloro-9-(4-methanesulfonylamino-2-methylamino-phenylamino)-acridine-4-carboxylic acid methylamide; hydrochloride 
• 102941-23-1 9-(4-Methanesulfonylamino-2-methylamino-phenylamino)-5-methoxy-acridine-4-carboxylic acid methylamide; hydrochloride 
• 88913-69-3 6-Chloro-9-(4-methanesulfonylamino-2-methylamino-phenylamino)-acridine-4-carboxylic acid methylamide; hydrochloride 
• 88913-56-8 [9-(4-Methanesulfonylamino-2-methylamino-phenylamino)-acridin-3-yl]-carbamic acid methyl ester; hydrochloride 
• 88913-72-8 N-[4-(4,5-Dimethoxy-acridin-9-ylamino)-3-methylamino-phenyl]-methanesulfonamide; hydrochloride 
• 88913-70-6 9-(4-Methanesulfonylamino-2-methylamino-phenylamino)-5-methyl-acridine-4-carboxylic acid methylamide; hydrochloride 
• 88913-54-6 N-[3-Methylamino-4-(3-nitro-acridin-9-ylamino)-phenyl]-methanesulfonamide; hydrochloride 
• 102941-21-9 N-[4-(3-Chloro-5-methoxy-acridin-9-ylamino)-3-methylamino-phenyl]-methanesulfonamide; hydrochloride 
• 102941-22-0 N-[4-(3-Bromo-5-methoxy-acridin-9-ylamino)-3-methylamino-phenyl]-methanesulfonamide; hydrochloride 
• 102941-20-8 N-[4-(3-Fluoro-5-methoxy-acridin-9-ylamino)-3-methylamino-phenyl]-methanesulfonamide; hydrochloride 
• 88913-61-5 9-(4-Methanesulfonylamino-2-methylamino-phenylamino)-acridine-4-carboxylic acid methylamide; hydrochloride 
• 102941-11-7 9-(4-Methanesulfonylamino-2-methylamino-phenylamino)-acridine-3-carboxylic acid methylamide; hydrochloride 

Relevant academic research and scientific papers

Potential Antitumor Agents. 47. 3'-Methylamino Analogues of Amsacrine with in Vivo Solid Tumor Activity

Replacement of the 3'-methoxy group of the clinical antileukemic agent amsacrine (1) with a 3'-methylamino group provides a compound (3) with a broader spectrum of action, including in vivo activity against experimental solid tumors.The synthesis, physico